Preterm birth (PTB) continues to pose a challenge in neonatal medicine, and it is the major cause of perinatal morbidity and ...

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...

Enveric's Akos Biosciences licensed its cannabinoid-COX-2 conjugate technology to Restoration Biologics for joint disease ...

The hemp law has prompted confusion among business owners and state officials since Gov. Phil Murphy signed the law in ...

A research team from the University of British Columbia Okanagan analyzed cannabis dosing and developed cannabis dosing guidelines comparable to guidelines | Health And Medicine ...

An F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. patent details new cannabinoid CB2 receptor modulators reported to be useful for the treatment of neuropathic pain, asthma, osteoporosis, ...

Research shows that the drug activates the cannabinoid neurotransmitter system (which protects the brain), and this stimulates the cholinergic system (which controls memory and learning ...

At the end of last year, it seemed like Tennessee’s final hemp-derived cannabinoid (“HDC”) rules would (finally) take effect as scheduled on ...

The study carried out by Dr Marta Moreno-Rodríguez in the UPV/EHU group showed that the neurotransmitter receptors in the cannabinoid family and certain choline-containing lipids in the brain ...